A carregar...
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Current standard-of-care (SOC) therapy for breast cancer includes targeted therapies such as endocrine therapy for estrogen receptor-alpha (ERα) positive; anti-HER2 monoclonal antibodies for human epidermal growth factor receptor-2 (HER2)-enriched; and general chemotherapy for triple negative breast...
Na minha lista:
| Publicado no: | Cells |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6406734/ https://ncbi.nlm.nih.gov/pubmed/30691108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8020089 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|